Evidence map›Paper›PMID 19651674›Full record

Trial reportVascular medicine (London, England)2009

The effect of L-arginine and creatine on vascular function and homocysteine metabolism.

Eiman Jahangir, Joseph A Vita, Diane Handy, Monica Holbrook, Joseph Palmisano, Ryan Beal, Joseph Loscalzo, Robert T Eberhardt

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Vascular medicine (London, England), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Eiman JahangirBoston University School of Medicine, Boston, MA 02118, USA.
Joseph A Vita
Diane Handy
Monica Holbrook
Joseph Palmisano
Ryan Beal
Joseph Loscalzo
Robert T Eberhardt
Boston University · USHarvard University · USUniversity School · US

Funding

Redox regulation in Endothelial Progenitor CellsP01HL081587 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WALSH, KENNETH · 2005 to 2015
$21.5M
Vascular Consequences of Insulin Resistance and ObesityP50HL083801 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI VITA, JOSEPH A. · 2006 to 2010
$11.2M
SCOR IN ISCHEMIC HEART DISEASE IN BLACKSP50HL055993 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LOSCALZO, JOSEPH · 1995 to 2004
$6.9M
Vitamin C, glutathione and NO action in humansP01HL060886 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI VITA, JOSEPH A. · 2000 to 2004
$5.4M
TREATMENT OF SICKLE CELL ANEMIAP60HL015157 · NHLBI · BOSTON MEDICAL CENTER · PI STEINBERG, MARTIN H. · 1985 to 2002
$5.4M
Clinical Utility of Endothelial Function in PADR01HL075795 · NHLBI · BOSTON MEDICAL CENTER · PI VITA, JOSEPH A. · 2003 to 2007
$4.9M
Boston University Medical Center Leadership Program in Vascular MedicineK12HL083781 · NHLBI · BOSTON MEDICAL CENTER · PI EBERHARDT, ROBERT THOMAS · 2007 to 2013
$3.4M
Determinants of Shear Stress-Mediated Arterial RemodelingR01HL083269 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI VITA, JOSEPH A. · 2006 to 2009
$1.9M
NHLBI NIH HHS HL083269NHLBI NIH HHS HL083781NHLBI NIH HHS HL15157-31NHLBI NIH HHS HL55993NHLBI NIH HHS HL60886NHLBI NIH HHS HL75795NHLBI NIH HHS K12 HL083781NHLBI NIH HHS P01 HL060886NHLBI NIH HHS P01 HL081587NHLBI NIH HHS P50 HL055993NHLBI NIH HHS P50 HL083801NHLBI NIH HHS R01 HL075795NHLBI NIH HHS R01 HL083269
6 · The paper itself

Abstract

Studies with L-arginine supplementation have shown inconsistent effects on endothelial function. The generation of guanidinoacetate (GAA) from L-arginine with subsequent formation of creatine and homocysteine and consumption of methionine may reduce the pool of L-arginine available for nitric oxide generation. Experimental studies suggest that creatine supplementation might block this pathway. We sought to determine the effects of L-arginine, creatine, or the combination on endothelium-dependent vasodilation and homocysteine metabolism in patients with coronary artery disease. Patients with coronary artery disease were randomized to L-arginine (9 g/day), creatine (21 g/day), L-arginine plus creatine, or placebo for 4 days (n = 26-29/group). Brachial artery flow-mediated dilation and plasma levels of L-arginine, creatine, homocysteine, methionine, and GAA were measured at baseline and follow-up. L-arginine and creatine supplementation had no effects on vascular function. L-arginine alone increased GAA (p < 0.01) and the ratio of homocysteine to methionine (p < 0.01), suggesting increased methylation demand. The combination of creatinine and L-arginine did not suppress GAA production or prevent the increase in homocysteine-to-methionine ratio. Unexpectedly, creatine supplementation (alone or in combination with L-arginine) was associated with an 11-20% increase in homocysteine concentration (p < 0.05), which was not attributable to worsened renal function, providing evidence against an effect of creatine on decreasing methylation demand. In conclusion, the present study provides no evidence that L-arginine supplementation improves endothelial function and suggests that l-arginine may increase methylation demand. Creatine supplementation failed to alter the actions of L-arginine on vascular function or suppress methylation demand. The unexpected increase in homocysteine levels following creatine supplementation could have adverse effects and merits further study, since creatine is a commonly used dietary supplement.

Indexed as

Dietary SupplementsAgedArginineBrachial ArteryCoronary Artery DiseaseCreatineFemaleGlycineHomocysteineHumansHyperemiaMaleMethionineMiddle AgedRegional Blood FlowTreatment OutcomeArginineCreatineGlycineglycocyamineHomocysteineMethionine

Identifiers

PMID19651674
PMCPMC2840406
OpenAlexW2116952808

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.